The 2nd ever Annual SNO Brain Metastases Conference, originally planned for Toronto from 13 to 15th August will be virtual this year.
This time coincides exactly with the companies schedule for release of clinical data in breast cancer brain metastases.
The data the company refers to - for sure is the Dana Farber 37 person trial that was mentioned by harvett in these posts 12 months ago.... associated with the 1st Brain Metastases Conference.
See link below, regarding some details of this international conference. NOTE the name of one of the Co-chairs.It so happens, as you would be aware - Priscilla Brastianos is linked with Dana Farber/MGH, where this Kazia BCBM trial has been conducted.
The schedule has not been released. It will be critical when the full schedule is released, to see details and even the possibility that Priscilla will present GDC 0084 conducted at her research hospital/institute. Suggest look for that full schedule release soon, as a significant guide as to success of the Kazia Trial. (Eg if GDC 0084 was not successful, I don't think Kazia would even get a mention at all during the 3 days. - so lets see the full schedule and form some views). This August meeting and as I suggest.....release of results is a very big deal for the company - coming of just that cap of under US$30m.
https://www.soc-neuro-onc.org/SNO/2020BrainMetastases/2020BrainMetastasesHome.aspx